Nurosene Health Inc.
Nurosene Health Inc. (MNNDF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mnndf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Nurosene Health Inc.You MNNDF | $14M | N/A | — | -$0.52 |
 Abingdon Health Plc ABDXF | $32M | N/A | — | -$0.01 |
 Cloud DX Inc. CDXFF | $10M | N/A | — | -$0.11 |
 NexgenRx Inc. NEGXF | $19M | 21.20x | — | $0.02 |
 Noxopharm Limited NOXOF | $15M | N/A | — | -$0.01 |
 Simply Better Brands Corp. PKANF | $15M | N/A | — | -$0.36 |
 RAMM Pharma Corp. RAMMF | $15M | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Nurosene Health Inc. (MNNDF) measures how much investors pay for each dollar of the company's trailing earnings. MNNDF's current PE ratio of N/A is calculated by dividing its stock price of $0.33 by its TTM earnings per share of -$0.52.
Frequently asked questions
MNNDF pe ratio · 6 questionsMNNDF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.33 and TTM EPS of -$0.52. Data sourced from Financial Modeling Prep via MNNDF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Nurosene Health Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09